An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam

Inclusion Criteria:

- Subjects with epilepsy who participated in previous brivaracetam trials which allow
access to the present trial.

- Subjects from whom the Investigator believes a reasonable potential benefit from the
long-term administration of brivaracetam may be expected.

Exclusion Criteria:

• Severe medical, neurological and psychiatric disorders, including current suicidal
ideation or behaviour, or laboratory values which may have an impact on the safety of the
subject, as determined by the investigator.